The North America Sustained Release Excipients Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
Excipients serve as polymeric screens for drug powders as well as multi-particulate systems in oral solid dose (OSD) forms as well as matrix formers in matrix delivery systems. Excipients in liquid oral products can help conceal tastes and shield the gastrointestinal membrane. Excipients can help prevent alcohol-induced dosage dumping and provide a misuse deterrent in some circumstances.
There are a number of factors taken into account when choosing particular excipients for sustained release formulations. To ensure that the required dissolution profiles can be obtained with a specific excipient, and that a satisfactory in vivo-in vitro correlation is attainable, dosage form kind and design are taken into account in addition to the solubility of API.
Concerns about patient cooperation and safety are also taken into account. Ethylcellulose continues to be the preferred polymer in multi-particulate medication delivery systems either with or without an extra coating platform. The choice of the polymer depends on the properties and kind of dosage form of the medicine.
In this region, chronic diseases are on the rise overall, according to trends. Heart disease, respiratory disorders, cancer, stroke, injuries, diabetes, Alzheimer's disease, pneumonia and influenza, renal disease, and septicemia are currently the top ten health issues in America. These issues get worse due to the aging population of the country, existing risk factors (poor nutrition, tobacco use, and lack of physical activity), and medical advancements that lengthen lifespan (if not also improve general health). The Centers for Disease Control estimate that chronic diseases alone in the United States account for around three-fourths of total healthcare costs annually.
The US market dominated the North America Sustained Release Excipients Market by Country in 2021; thereby, achieving a market value of $404.2 million by 2028. The Canada market is experiencing a CAGR of 10.2% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.3% during (2022 - 2028).
Based on Route of Administration, the market is segmented into Oral, Transdermal, Vaginal, Intravenous, Ophthalmic, Subcutaneous, Intramuscular, and Others. Based on Product, the market is segmented into Polymers, Minerals, Sugars, Gelatin & Chitosan, and Others. Based on Technology, the market is segmented into Targeted Delivery, Implants, Wurster Technique, Transdermal, Micro Encapsulation, and Coacervation & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Sustained Release Excipients Market is Predict to reach $1.9 Billion by 2028, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefossé, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.
By Route of Administration
By Product
By Technology
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 